Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma

  • A. Abu-Sanad
  • A. Warsi
  • R. P. Michel
  • A. Nahal
  • G. Popradi
  • J.M. Storring
  • A.S. Liberman
  • T. Alcindor

Abstract

Histiocytic sarcoma is diagnosed according to established criteria. However, treatment is controversial: although lymphoma chemotherapy regimens are often used, their impact on the natural history of the disease is unclear. Here, we report a disease-free survival of 2 years after autologous stem-cell transplantation in a patient with relapsed histiocytic sarcoma.
How to Cite
Abu-Sanad, A., Warsi, A., Michel, R. P., Nahal, A., Popradi, G., Storring, J., Liberman, A., & Alcindor, T. (1). Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma. Current Oncology, 19(4), e289-291. https://doi.org/10.3747/co.19.964
Section
Case Report